van Duijn E, Roos R A C, Smarius L J C A, van der Mast R C
Leids Universitair Medisch Centrum, Leiden.
Ned Tijdschr Geneeskd. 2005 Sep 24;149(39):2141-4.
Two patients, a 50-year-old man and a 51-year-old woman, with genetically confirmed Huntington's disease (HD) were admitted to a psychiatric department because of therapy-resistant major depression. Both patients were successfully treated with electroconvulsive therapy (ECT). The lifetime prevalence of depression in HD patients is high and, together with movement and cognitive disturbances, causes a heavy disease burden for patients and their families. ECT is an effective and relatively fast antidepressive treatment. Although ECT use has been reported in only 11 depressive HD patients in the literature, in our opinion it is an adequate antidepressive treatment that should be considered before further drug treatment for patients who are substantially limited in their daily functioning.
两名经基因确诊患有亨廷顿舞蹈症(HD)的患者,分别为一名50岁男性和一名51岁女性,因难治性重度抑郁症入住精神科。两名患者均通过电休克疗法(ECT)成功治愈。HD患者中抑郁症的终生患病率很高,与运动和认知障碍一起,给患者及其家庭带来沉重的疾病负担。ECT是一种有效且相对快速的抗抑郁治疗方法。虽然文献中仅报道了11例患有抑郁症的HD患者接受ECT治疗,但我们认为,对于日常功能严重受限的患者,在进一步药物治疗之前,ECT是一种合适的抗抑郁治疗方法,应予以考虑。